n-methyladenosine has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, X; Jin, Y; Kong, L; Li, Z; Song, M; Wei, J; Yang, J; Zhang, C; Zhang, Y; Zheng, H | 1 |
| Gu, HY; Hu, C; Huang, ZD; Lin, LL; Liu, ZZ; Wei, RX | 1 |
| Chen, Y; Cong, L; Guo, X; Hou, M; Pan, C | 1 |
3 other study(ies) available for n-methyladenosine and Sarcoma
| Article | Year |
|---|---|
m
Topics: Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genomics; Humans; Methylation; Neoplasm Proteins; Sarcoma; Transcriptome; Tumor Microenvironment | 2022 |
m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
Topics: Adenosine; Antineoplastic Agents; Deoxycytidine; DNA Copy Number Variations; DNA Methylation; Docetaxel; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Kaplan-Meier Estimate; Sarcoma | 2021 |
A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
Topics: Adenosine; Databases, Genetic; Disease-Free Survival; DNA Copy Number Variations; DNA Methylation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Male; Middle Aged; Multivariate Analysis; Mutation; Prognosis; Proportional Hazards Models; RNA, Messenger; Sarcoma | 2020 |